Overview
Over its long history, the Biopharmaceutical (BIOP) Section of the American Statistical Association (ASA) has fostered community and created a shared sense of purpose among statisticians in the medical product industry. The year 2021 marks the 40th Anniversary of BIOP. It is a time to reflect on how the Section has grown from its humble roots, a time to celebrate the activities and accomplishments of the Section as it seeks to support its members, and a time to envision how the Section will continue to lead the way to address the challenges of medical product development in the 21st Century.
|
|
Read more about our history! Free (1990) summarizes a brief, early history of the Section in The American Statistician. Numerous BIOP members updated this history in very rich detail from Committee, Subsection, and early Section years through 1988 (Davis et al., 2005). As part of the ASA 175th Anniversary Celebrations, Sanchez-Kam, Bhattacharyya & Price D (2014) updated the BIOP history through 2014. Of course, more recent history is continually added to the History page under the About Us tab of the BIOP website. As you review our history, ask yourself, how can I add to this amazing legacy of activity?
There are numerous activities planned for 2021. Watch this space as we update details!
JSM in Seattle*
|
- Panel discussions with past BIOP chairs
- Celebrate at the BIOP Open Business Meeting with games, food, fun and reminiscing
|
RISW in Rockville*
|
- Panel discussions with past BIOP chairs
- Celebrate at the BIOP Open Business Meeting with games, food, fun and reminiscing
|
Biopharmaceutical Report
|
- Articles in each report highlight the activities and successes of BIOP over 10-year increments in our history
|
ASA Connect / BIOP Community
|
|
*While we are planning for in-person activities, we will adapt as needed due to any lingering safety concerns surrounding COVID-19.
We welcome you to join us as we celebrate the 40th Anniversary of the Biopharmaceutical Section!
Steering Committee Members
Margaret (Meg) Gamalo – Co-chair [Pfizer]
|
Margaret.Gamalo@pfizer.com
|
Jennifer Gauvin – Co-Chair [Novartis]
|
jennifer.gauvin@novartis.com
|
Veronica Bubb
|
vbubb@abondcro.com
|
Lisa Lupinacci [Merk]
|
lisa_lupinacci@merck.com
|
Richard Zink [Lexitas]
|
Richard.Zink@lexitas.com
|
Volunteers: Ludovic Trinquart [Boston University], Jianchang Lin [Takeda], Hiya Banerjee [Novartis], Meijing Wu [Abbvie], Yodit Seifu [Merck]
How to participate: Please email any member of the steering committee or biop40th@gmail.com if you would like to get involved.
Upcoming Activities/Announcements
Announcements to be updated on a quarterly basis.
†Pre-specified rule based on highest citation and citation per year.
References:
Davis RL, Free SM, Gulyas SW, Hearron MS, Lindborg SR, O’Neill R & Sampson CB. (2005). The History of the Biopharmaceutical Section of the American Statistical Association (ASA), 1966-1988. The Biopharmaceutical Report 13: 2-7. Available at: https://higherlogicdownload.s3.amazonaws.com/AMSTAT/fa4dd52c-8429-41d0-abdf-0011047bfa19/UploadedImages/BIOP%20Report/2005_Winter_BR.pdf.
Free SM. (1990). Some History for the Biopharmaceutical Section. The American Statistician 44: 80-82.
Sanchez-Kam M, Bhattacharyya A & Price D. (2014). The History of the Biopharmaceutical Section of the American Statistical Association. Poster presented at the 2014 Regulatory-Industry Statistics Workshop. Available at: https://higherlogicdownload.s3.amazonaws.com/AMSTAT/fa4dd52c-8429-41d0-abdf-0011047bfa19/UploadedImages/Biopharm_History_Poster_for_JSM_FINAL_16JUL14.pdf.